• Tue news: Obesity pill race heats up. Express Scripts sues FTC. More ESMO data. Kairos IPO. Daiichi-Merck guided-missile cancer drug. See more on our front page

Coya taps familiar friend Dr. Reddy’s to commercialize ALS med

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 06, 2023 at 09:02: PM
via Neurodegenerative biotech Coya Therapeutics has handed over key commercialization rights to an amyotrophic lateral sclerosis prospect to existing partner Dr. Reddy’s, and it's also fundraising off the deal.

article source
 




Similar threads

cafead
Coya deems dementia drug R&D plan 'premature,' switches focus
Replies
0
Views
62
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Coya Therapeutics reports data from Alzheimer’s Disease therapy trial
Replies
0
Views
100
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Treg cell therapy showing promise in ALS trials: Coya Therapeutics
Replies
0
Views
105
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novartis taps Lindy to turn biologic drugs into at-home injectables, puts nearly $1B on the line
Replies
0
Views
29
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Sanofi taps Belharra for immune drug research
Replies
0
Views
21
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote